Phase I pilot clinical trial of antenatal maternally administered melatonin to decrease the level of oxidative stress in human pregnancies affected by pre-eclampsia (PAMPR): Study protocol

Citation

Hobson, S, Lim, R, Gardiner, E et al. 2013, 'Phase I pilot clinical trial of antenatal maternally administered melatonin to decrease the level of oxidative stress in human pregnancies affected by pre-eclampsia (PAMPR): Study protocol', BMJ Open, vol. 3, no. 9, pp. e003788-e003788.

Year

2013

Fields of Research

  • Receptors And Membrane Biology
  • Receptors And Membrane Biology

Updated:  17 January 2021 / Responsible Officer:  Director (Research Services Division) / Page Contact:  Researchers